Investment & M&A transaction comps
Supplements Investment & M&A Transaction Comps
Explore investment and M&A transactions tagged supplements. Compare companies, buyers, dates and available valuation multiples, with reported, estimated or rumored figures clearly labelled in each comp.
Coverage includes published FundComb transactions carrying this tag. Each comp preserves its own source notes and valuation basis.
- Reviewed transactions
- 71
- With value data
- 42
- With revenue multiples
- 36
- Transaction years
- 2005–2026
Sortable transaction comps
Supplements transaction table
Rows with reported value
16 / 25
Acquisition EV, USD
USD 33B
Investment EV, USD
USD 2.3B
Median EV / revenue
3.7x
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
25 shown of 71 matching transactions. Click any transaction row for more detail.
Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately, and a financing without a reported valuation shows its amount raised, not an EV.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| AuNutra Industries Control | 2026-10-19 | Vivify Specialty Ingredients | Undisclosed | Undisclosed | - | - | - | Confirmed 2 sources | ||
| Specnova Control | 2026-10-09 | HTBA | Undisclosed | Undisclosed | - | - | United States | Confirmed 2 sources | ||
| Medici Brands Capital Raise | 2026-09-02 | Greenoaks; Valor Equity Partners; Peter Rahal; Iconiq; Imaginary Ventures | USD 2.3B Enterprise Value | 2,250 | 7.5x | - | United States | Confirmed 3 sources | ||
| Twinlab Control | 2026-09-02 | cbdMD | Undisclosed Consideration | Undisclosed | - | - | - | Confirmed 4 sources | ||
| Nestlé Holistic Health Platform Control | 2026-09-01 | Yellow Wood Partners | USD 1.0B Consideration | 1,000 | - | - | - | Confirmed 2 sources | ||
| Jamieson Wellness Control (100%) | 2026-08-06 | Kirin Holdings Company | CAD 2.5B Enterprise Value | 1,785 | - | - | Canada | Confirmed 1 source | ||
| Thorne Control | 2026-08-04 | Procter & Gamble | USD 3.8B Consideration | 3,800 | 7.6x | - | United States | Estimated 3 sources | ||
| BIO-CAT Enzymes & Microbials Control | 2026-07-31 | Lallemand Inc. | Undisclosed | Undisclosed | - | - | United States | Confirmed 1 source | ||
| Vitabiotics Control | 2026-07-24 | Bain Capital | USD 1.0B Estimated Enterprise Value | 1,038 | - | - | United Kingdom | Confirmed 3 sources | ||
| IM8 Capital Raise | 2026-07-14 | General Catalyst Customer Value Fund | Undisclosed Undisclosed | Undisclosed | - | - | - | Confirmed 3 sources | ||
| Imaraïs Beauty Control | 2026-05-18 | Healthy Extracts | USD 20.0M Consideration | 20 | - | - | - | Confirmed 1 source | ||
| SuppCo Control | 2026-05-13 | Function | Undisclosed | Undisclosed | - | - | - | Confirmed 1 source | ||
| Tally Health Control | 2026-04-29 | Infinite Epigenetics | Undisclosed | Undisclosed | - | - | - | Confirmed 2 sources | ||
| Grüns Control (80%) | 2026-04-09 | Unilever | EUR 959M Enterprise Value | 1,120 | 3.7x | - | United States | Estimated 7 sources | ||
| Huel Control (100%) | 2026-03-23 | Danone | EUR 1.0B Enterprise Value | 1,160 | 3.5x | 34.8x | United Kingdom | Estimated 3 sources | ||
| Zywie Ventures Private Limited (OZiva) Control (49%) | 2026-02-12 | Hindustan Unilever Limited (HUL) | INR 17B Enterprise Value | 186 | 3.5x | - | India | Confirmed 6 sources | ||
| Nutraceutical Wellness, Inc. (Nutrafol) Minority (20%) | 2025-04-01 | Unilever | Undisclosed Investment Amount | Undisclosed | - | - | - | Confirmed 5 sources | ||
| GHOST Lifestyle LLC Control (60%) | 2024-12-31 | Keurig Dr Pepper Inc. | USD 1.7B Enterprise Value | 1,665 | - | - | - | Estimated 54 sources | ||
| Opella Control (50%) | 2024-10-21 | Clayton, Dubilier & Rice | EUR 16B Enterprise Value | 17,365 | 3.1x | 14.0x | France, United States & Global | Confirmed 1 source | ||
| Sunday Natural Control (55%) | 2024-01-15 | CVC Capital Partners | EUR 800M Enterprise Value | 875 | 8.0x | 16.0x | Germany | Estimated 1 source | ||
| Lactobio Control | 2023-12-04 | L’Oréal | Undisclosed Undisclosed | Undisclosed | - | - | Denmark | Confirmed 1 source | ||
| Bonafide Health Control | 2023-11-30 | Pharmavite | USD 425M Consideration | 425 | - | - | - | Confirmed 1 source | ||
| Thorne HealthTech Control | 2023-08-28 | L Catterton | USD 681M Enterprise Value | 681 | 3.7x | 21.2x | - | Estimated 2 sources | ||
| Blackmores Control (100%) | 2023-04-26 | Kirin | USD 1.2B Enterprise Value | 1,241 | 2.9x | 23.1x | Australia | Estimated 3 sources | ||
| Adare Biome Control (100%) | 2023-04-19 | dsm-firmenich AG | EUR 275M Enterprise Value | 301 | - | 18.0x | France & Global | Confirmed 1 source |
Explore related tags
Continue to the full transaction history for each tag.
Explore buyers & investors
Source coverage varies by transaction. Announced deals, minority investments and capital raises retain their own labels; an investment amount is separate from enterprise value. Read the methodology.